Literature DB >> 8707269

Altered lipid metabolism in apolipoprotein E-deficient mice does not affect cholesterol balance across the liver.

F Kuipers1, J M van Ree, M H Hofker, H Wolters, G In't Veld, R Havinga, R J Vonk, H M Princen, L M Havekes.   

Abstract

Adaptation of cholesterol and bile acid synthesis and of biliary cholesterol secretion represent key metabolic responses to maintain cholesterol homeostasis and have been suggested to be influenced by apolipoprotein E (apoE) phenotype in humans. We have investigated hepatic metabolism and secretion of cholesterol into bile in homozygous apoE-deficient (apoE -/-) mice fed normal lab chow. Plasma cholesterol levels were 10 times higher in apoE (-/-) mice than in controls (+/+); triacylglycerol levels were only minimally affected. Hepatic cholesterol (+56%) and triacylglycerol (+232%) contents were significantly increased in apoE (-/-) mice, whereas those of cholesteryl ester and of phospholipids were similar in both groups. Lipid accumulated predominantly in periportal areas of apoE (-/-) livers. Hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG CoA reductase) messenger RNA (mRNA) level and activity were reduced by 45% and 50%, respectively, in apoE (-/-) mice. In contrast, plasma lathosterol/cholesterol ratios, indicative for whole-body cholesterol synthesis, were fourfold increased in these mice. Acyl-coenzyme A:cholesterol acyltransferase (ACAT) activity was similar in livers of both groups. Despite the marked changes in hepatic cholesterol metabolism, neither hepatic bile acid synthesis, bile acid pool size and composition, nor hepatic cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase mRNA levels differed between apoE (-/-) and (+/+) mice. In addition, biliary cholesterol secretion was unaffected in the knock-out mice. Our results show that lack of apoE leads to marked changes in hepatic cholesterol metabolism without altering cholesterol balance across the liver. The data are compatible with increased peripheral cholesterol biosynthesis in apoE-deficient mice.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8707269     DOI: 10.1002/hep.510240138

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  15 in total

1.  Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice.

Authors:  Johanna H M Stroeve; Gemma Brufau; Frans Stellaard; Frank J Gonzalez; Bart Staels; Folkert Kuipers
Journal:  Lab Invest       Date:  2010-06-07       Impact factor: 5.662

2.  Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MS.

Authors:  Yazen Alnouti; Iván L Csanaky; Curtis D Klaassen
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-09-03       Impact factor: 3.205

3.  Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis.

Authors:  Mònica Tous; Natàlia Ferré; Jordi Camps; Francesc Riu; Jorge Joven
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

4.  Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice.

Authors:  Tineke Kok; Vincent W Bloks; Henk Wolters; Rick Havinga; Peter L M Jansen; Bart Staels; Folkert Kuipers
Journal:  Biochem J       Date:  2003-02-01       Impact factor: 3.857

5.  The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance.

Authors:  Melinde Wijers; Paolo Zanoni; Nalan Liv; Dyonne Y Vos; Michelle Y Jäckstein; Marieke Smit; Sanne Wilbrink; Justina C Wolters; Ydwine T van der Veen; Nicolette Huijkman; Daphne Dekker; Niels Kloosterhuis; Theo H van Dijk; Daniel D Billadeau; Folkert Kuipers; Judith Klumperman; Arnold von Eckardstein; Jan Albert Kuivenhoven; Bart van de Sluis
Journal:  JCI Insight       Date:  2019-06-06

6.  Efficient reabsorption of transintestinally excreted cholesterol is a strong determinant for cholesterol disposal in mice.

Authors:  Ivo P van de Peppel; Anna Bertolini; Theo H van Dijk; Albert K Groen; Johan W Jonker; Henkjan J Verkade
Journal:  J Lipid Res       Date:  2019-07-19       Impact factor: 5.922

7.  Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E- deficient mouse hepatocytes.

Authors:  F Kuipers; M C Jong; Y Lin; M Eck; R Havinga; V Bloks; H J Verkade; M H Hofker; H Moshage; T J Berkel; R J Vonk; L M Havekes
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

8.  Defective lipid delivery modulates glucose tolerance and metabolic response to diet in apolipoprotein E-deficient mice.

Authors:  Susanna M Hofmann; Diego Perez-Tilve; Todd M Greer; Beth A Coburn; Erin Grant; Joshua E Basford; Matthias H Tschöp; David Y Hui
Journal:  Diabetes       Date:  2007-10-03       Impact factor: 9.461

9.  Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation.

Authors:  Eung Ju Kim; Baek-hui Kim; Hong Seog Seo; Yong Jik Lee; Hyun Hee Kim; Hyun-Hwa Son; Man Ho Choi
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

10.  Hepatic farnesoid X-receptor isoforms α2 and α4 differentially modulate bile salt and lipoprotein metabolism in mice.

Authors:  Marije Boesjes; Vincent W Bloks; Jurre Hageman; Trijnie Bos; Theo H van Dijk; Rick Havinga; Henk Wolters; Johan W Jonker; Folkert Kuipers; Albert K Groen
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.